Home » Newsletters » BioWorld Science

BioWorld Science

June 9, 2022

View Archived Issues

Humanwell Healthcare discloses LPAR1 antagonists

CURACLE and collaborators patent carbazole derivative angiogenesis inhibitors

French researchers patent gold complexes and their use as antioxidants

ATP spreads inflammation by activating neural pathway and enhancing IL-6 amplifier

Ningbo Combireg Pharmaceutical Technology presents deuterated anticancer compounds

Platelet-activating factor receptor antagonists discovered at Boehringer Ingelheim

Novel polyphenol derivative as potent DYRK1A inhibitor for the treatment of MS

Cilagicin, next-generation antibiotic with activity against MDR isolates

High-throughput proteomics identifies biomarkers of both rheumatoid arthritis and SLE

FDA clears Passage Bio's IND for PBML-04 for metachromatic leukodystrophy

Qualigen Therapeutics initiates IND-enabling studies for QN-302

OnCusp licenses ex-China rights to Multitude's CDH6 antibody-drug conjugate

China's NMPA approves IND for B7H4x4-1BB bispecific antibody HBM-7008

MetasTx advances MTX-101 for prostate cancer and metastasis prevention

FDA clears IND application for SBT-115301 for autoimmune disease

For mutations, "synonymous" is not a synonym for silent, study finds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...